| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/20/2001 | US6204238 Fatty acid derivatives and their use as surfactants in detergents and cleaners |
| 03/20/2001 | US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation |
| 03/15/2001 | WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/13/2001 | US6201153 Synthesis of midodrine HCI from a novel intermediate 1-(2′,5′-dimethoxyphenyl)-2-azidoethanone |
| 03/13/2001 | US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders |
| 03/13/2001 | US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/08/2001 | WO2001016211A1 Amphipathic compound having dendritic structure |
| 03/08/2001 | WO2001016090A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | CA2384191A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080070A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080067A1 Biodegradable corrosion inhibitors |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/06/2001 | US6197798 Inhibitors of microsomal triglyceride transfer protein |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197332 Lipid-conjugated polyamide compounds and related compositions and methods thereof |
| 03/01/2001 | WO2000058270A3 Hsv primase inhibitors |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | CN1285346A Process for preparation of 4.4' diaminophenylacyl substituted aniline |
| 02/27/2001 | US6194615 Useful as crosslinkers in coatings applications |
| 02/27/2001 | US6194612 Template for solution phase synthesis of combination libraries |
| 02/27/2001 | US6194418 Bactericides, pesticides |
| 02/22/2001 | WO2001012591A1 Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 02/22/2001 | WO2001012588A1 Salicylamide derivatives |
| 02/22/2001 | WO2001012587A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19938737A1 Aminosalicylsäureamide Aminosalicylamides |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP0835238B1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/15/2001 | WO2001010821A1 Multivalent exocyclic diketo compounds |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | WO2001010429A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | DE19741356C2 Verwendung von Glucoprotaminen Use of Glucoprotaminen |
| 02/14/2001 | EP1075462A2 Process for the preparation of s- n,n'- bis 2- hydroxy-1- (hydroxymethyl) ethyl]-5- (2- hydroxy-1- oxopropyl)- amino]- 2,4,6- triiodo- 1,3- benzenedicarboxamide |
| 02/14/2001 | EP0877729B1 Azlactone-based surfactants |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/14/2001 | CN1284058A Neuroprotective agents |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1284056A Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 02/13/2001 | US6187905 Peptide compound which inhibits viral proteinases; viricides for hepatitis c, hepatitis g, and human gb viruses |
| 02/08/2001 | WO2001009083A1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides |
| 02/08/2001 | WO2001009079A1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/07/2001 | EP1073643A2 New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 02/07/2001 | EP1073641A2 New substituted amides, their production and their use |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | EP1073623A1 Substituted amino acids as erythropoietin mimetics |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184345 Stable under solid phase synthesis conditions |
| 02/06/2001 | US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 02/06/2001 | US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 02/01/2001 | CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | CA2010929C Process for preparing nitriloamides |
| 01/30/2001 | CA1341173C Fungicides |